Thomas Broge

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Illuminating viral infections in the nervous system

Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies

Generation of improved humanized mouse models for human infectious diseases

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

Infectious diseases in humanized mice

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Persistence and pathogenesis of the neurotropic polyomavirus JC

Detection of JC Virus-Specific Immune Responses in a Novel Humanized Mouse Model

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies

JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy